Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
CLGN

Overview Financials Analysis Smart Money

CollPlant Biotechnologies Ltd.

CLGN · NASDAQ

Analyze with AI

Filings1

Total reported value$5.4K

Manager	Shares	Value	Change
Parallel Advisors, LLC	3.3K	$5.4K	-0.0%

SymbolCLGN

Market Cap$21.0M

IPO Date2018-01-31

CEOYehiel Tal

Employees57

SectorHealthcare

IndustryBiotechnology

CountryIL

ExchangeNASDAQ Global Market

cbdMD, Inc.

YCBD

$2.29

+60.13%

Agape ATP Corporation

ATPC

$0.143

+58.89%

Inspirato Incorporated

ISPO

$4.16

+46.30%

Aditxt, Inc.

ADTX

$1.97

+38.73%

Akanda Corp.

AKAN

$0.9822

+31.84%

Peers

NeurAxis, Inc.

NRXS · NASDAQ

$2.71

+0.37%

Enlivex Therapeutics Ltd.

ENLV · NASDAQ

$0.8467

+0.08%

NeuroSense Therapeutics Ltd.

NRSN · NASDAQ

$0.8346

-1.81%

Exicure, Inc.

XCUR · NASDAQ

$6.14

+1.35%

Klotho Neurosciences, Inc.

KLTO · NASDAQ

$0.3835

-1.67%

Cadrenal Therapeutics, Inc. Common Stock

CVKD · NASDAQ

$8.38

+1.58%

Sonnet BioTherapeutics Holdings, Inc.

SONN · NASDAQ

$1.26

-59.35%

Rallybio Corporation

RLYB · NASDAQ

$0.769

+0.13%

TAO Synergies Inc.

TAOX · NASDAQ

$5.42

-2.17%

MetaVia Inc.

MTVA · NASDAQ

$7.97

-2.09%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.